Table 1.
Category | Responses |
---|---|
Mean age, years | 61 |
Male sex | 30 (50) |
Race/ethnicity White/Caucasian Hispanic/Latino Native American/American Indian Black/African American Asian/Pacific Islander Other Preferred not to answer |
39 (65) 11 (18.3) 2 (3.3) 2 (3.3) 1 (1.7) 2 (3.3) 3 (5) |
No previous use of a non–GLP-1 receptor agonist injectable agent | 34 (56.7) |
Education College, graduate level College, undergraduate level High school Less than high school |
22 (36.7) 19 (31.7) 15 (25) 4 (6.7) |
English as first language | 56 (93.3) |
Diabetes duration, years >10 6–10 1–5 <1 year or unknown |
21 (35) 12 (20) 21 (35) 6 (10) |
NVS health literacy score 0–1 (limited) 2–3 (possibly limited) 4–6 (adequate) |
10 (16.7) 12 (20) 38 (63.3) |
Data are n (%) unless otherwise noted.